ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 125 filers reported holding ARRAY BIOPHARMA INC in Q2 2013. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $550,000 | -90.4% | 120,612 | -84.8% | 0.05% | -90.5% |
| Q2 2015 | $5,714,000 | +28.7% | 792,571 | +31.6% | 0.56% | +28.3% |
| Q1 2015 | $4,440,000 | +3569.4% | 602,451 | +2165.6% | 0.44% | +4250.0% |
| Q2 2014 | $121,000 | -92.4% | 26,591 | -91.7% | 0.01% | -86.7% |
| Q4 2013 | $1,600,000 | -63.9% | 319,430 | -55.2% | 0.08% | -62.9% |
| Q3 2013 | $4,432,000 | +30.1% | 712,491 | -5.0% | 0.20% | +41.3% |
| Q2 2013 | $3,407,000 | – | 750,360 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |